BRIGHTCOVE (BCOV) Fundamental Analysis & Valuation

NASDAQ:BCOV • US10921T1016

Current stock price

4.45 USD
+0.01 (+0.23%)
At close:
4.45 USD
0 (0%)
After Hours:

This BCOV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. BCOV Profitability Analysis

1.1 Basic Checks

  • BCOV had positive earnings in the past year.
  • BCOV had a positive operating cash flow in the past year.
  • BCOV had negative earnings in 4 of the past 5 years.
  • In the past 5 years BCOV always reported a positive cash flow from operatings.
BCOV Yearly Net Income VS EBIT VS OCF VS FCFBCOV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M -20M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -4.34%, BCOV is in line with its industry, outperforming 40.51% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -9.58%, BCOV is in line with its industry, outperforming 41.77% of the companies in the same industry.
Industry RankSector Rank
ROA -4.34%
ROE -9.58%
ROIC N/A
ROA(3y)-4.02%
ROA(5y)-5.56%
ROE(3y)-9.19%
ROE(5y)-12.88%
ROIC(3y)N/A
ROIC(5y)N/A
BCOV Yearly ROA, ROE, ROICBCOV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 -10 -20

1.3 Margins

  • Looking at the Gross Margin, with a value of 61.60%, BCOV belongs to the top of the industry, outperforming 81.01% of the companies in the same industry.
  • In the last couple of years the Gross Margin of BCOV has remained more or less at the same level.
  • BCOV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 61.6%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.06%
GM growth 5Y0.65%
BCOV Yearly Profit, Operating, Gross MarginsBCOV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. BCOV Health Analysis

2.1 Basic Checks

  • BCOV does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, BCOV has more shares outstanding
  • There is no outstanding debt for BCOV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BCOV Yearly Shares OutstandingBCOV Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
BCOV Yearly Total Debt VS Total AssetsBCOV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

  • Based on the Altman-Z score of 0.08, we must say that BCOV is in the distress zone and has some risk of bankruptcy.
  • BCOV has a worse Altman-Z score (0.08) than 83.54% of its industry peers.
  • BCOV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 0.08
ROIC/WACCN/A
WACC10.73%
BCOV Yearly LT Debt VS Equity VS FCFBCOV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M 100M

2.3 Liquidity

  • A Current Ratio of 0.75 indicates that BCOV may have some problems paying its short term obligations.
  • BCOV has a Current ratio of 0.75. This is amonst the worse of the industry: BCOV underperforms 88.61% of its industry peers.
  • BCOV has a Quick Ratio of 0.75. This is a bad value and indicates that BCOV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • BCOV has a Quick ratio of 0.75. This is amonst the worse of the industry: BCOV underperforms 88.61% of its industry peers.
Industry RankSector Rank
Current Ratio 0.75
Quick Ratio 0.75
BCOV Yearly Current Assets VS Current LiabilitesBCOV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. BCOV Growth Analysis

3.1 Past

  • BCOV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 145.45%, which is quite impressive.
  • BCOV shows a decrease in Revenue. In the last year, the revenue decreased by -0.22%.
  • BCOV shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.07% yearly.
EPS 1Y (TTM)145.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-60%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y0.64%
Revenue growth 5Y4.07%
Sales Q2Q%-2.02%

3.2 Future

  • Based on estimates for the next years, BCOV will show a very strong growth in Earnings Per Share. The EPS will grow by 64.74% on average per year.
  • The Revenue is expected to grow by 0.01% on average over the next years.
EPS Next Y100%
EPS Next 2Y64.74%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.51%
Revenue Next 2Y0.01%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BCOV Yearly Revenue VS EstimatesBCOV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
BCOV Yearly EPS VS EstimatesBCOV Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025 0 0.2 -0.2 0.4

More info and screens

Find the best growth stocksShow best growing peers

3

4. BCOV Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 89.00, which means the current valuation is very expensive for BCOV.
  • BCOV's Price/Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Earnings ratio is at 27.53. BCOV is valued rather expensively when compared to this.
  • The Price/Forward Earnings ratio is 124.65, which means the current valuation is very expensive for BCOV.
  • BCOV's Price/Forward Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 37.95. BCOV is valued rather expensively when compared to this.
Industry RankSector Rank
PE 89
Fwd PE 124.65
BCOV Price Earnings VS Forward Price EarningsBCOV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • BCOV's Enterprise Value to EBITDA is on the same level as the industry average.
  • BCOV's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 51.96
EV/EBITDA 23.8
BCOV Per share dataBCOV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as BCOV's earnings are expected to grow with 64.74% in the coming years.
PEG (NY)0.89
PEG (5Y)N/A
EPS Next 2Y64.74%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BCOV Dividend Analysis

5.1 Amount

  • No dividends for BCOV!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

BCOV Fundamentals: All Metrics, Ratios and Statistics

BRIGHTCOVE

NASDAQ:BCOV (2/3/2025, 8:15:51 PM)

After market: 4.45 0 (0%)

4.45

+0.01 (+0.23%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)11-04
Earnings (Next)02-20
Inst Owners70.58%
Inst Owner Change0%
Ins Owners5.23%
Ins Owner Change0%
Market Cap201.05M
Revenue(TTM)199.83M
Net Income(TTM)-9.14M
Analysts45.71
Price Target4.54 (2.02%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)100%
Min EPS beat(2)56.43%
Max EPS beat(2)143.57%
EPS beat(4)4
Avg EPS beat(4)114.38%
Min EPS beat(4)56.43%
Max EPS beat(4)161.44%
EPS beat(8)6
Avg EPS beat(8)77.66%
EPS beat(12)10
Avg EPS beat(12)100.79%
EPS beat(16)14
Avg EPS beat(16)114.38%
Revenue beat(2)2
Avg Revenue beat(2)0.71%
Min Revenue beat(2)0.56%
Max Revenue beat(2)0.87%
Revenue beat(4)2
Avg Revenue beat(4)-0.15%
Min Revenue beat(4)-1.91%
Max Revenue beat(4)0.87%
Revenue beat(8)2
Avg Revenue beat(8)-1%
Revenue beat(12)6
Avg Revenue beat(12)-0.14%
Revenue beat(16)10
Avg Revenue beat(16)0.35%
PT rev (1m)0%
PT rev (3m)14.84%
EPS NQ rev (1m)0%
EPS NQ rev (3m)50%
EPS NY rev (1m)N/A
EPS NY rev (3m)100%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.39%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.25%
Valuation
Industry RankSector Rank
PE 89
Fwd PE 124.65
P/S 1.01
P/FCF 51.96
P/OCF 14.73
P/B 2.11
P/tB 11.84
EV/EBITDA 23.8
EPS(TTM)0.05
EY1.12%
EPS(NY)0.04
Fwd EY0.8%
FCF(TTM)0.09
FCFY1.92%
OCF(TTM)0.3
OCFY6.79%
SpS4.42
BVpS2.11
TBVpS0.38
PEG (NY)0.89
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -4.34%
ROE -9.58%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 61.6%
FCFM 1.94%
ROA(3y)-4.02%
ROA(5y)-5.56%
ROE(3y)-9.19%
ROE(5y)-12.88%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.06%
GM growth 5Y0.65%
F-Score7
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 50.16%
Cap/Sales 4.89%
Interest Coverage N/A
Cash Conversion 186.6%
Profit Quality N/A
Current Ratio 0.75
Quick Ratio 0.75
Altman-Z 0.08
F-Score7
WACC10.73%
ROIC/WACCN/A
Cap/Depr(3y)143.44%
Cap/Depr(5y)123.4%
Cap/Sales(3y)7.87%
Cap/Sales(5y)6.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)145.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-60%
EPS Next Y100%
EPS Next 2Y64.74%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y0.64%
Revenue growth 5Y4.07%
Sales Q2Q%-2.02%
Revenue Next Year-1.51%
Revenue Next 2Y0.01%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y51.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year979.3%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y4.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-44.43%
OCF growth 3Y-40.43%
OCF growth 5Y12.05%

BRIGHTCOVE / BCOV Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BRIGHTCOVE?

ChartMill assigns a fundamental rating of 3 / 10 to BCOV.


What is the valuation status for BCOV stock?

ChartMill assigns a valuation rating of 3 / 10 to BRIGHTCOVE (BCOV). This can be considered as Overvalued.


Can you provide the profitability details for BRIGHTCOVE?

BRIGHTCOVE (BCOV) has a profitability rating of 3 / 10.


What is the expected EPS growth for BRIGHTCOVE (BCOV) stock?

The Earnings per Share (EPS) of BRIGHTCOVE (BCOV) is expected to grow by 100% in the next year.